- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting CD24 as a novel immunotherapy for solid cancers
Authors
Keywords
-
Journal
Cell Communication and Signaling
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-02
DOI
10.1186/s12964-023-01315-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR‑122/SENP1 axis confers stemness and chemoresistance to liver cancer through Wnt/β‑catenin signaling
- (2023) Jianbo Dai et al. Oncology Letters
- Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity
- (2022) Adrià Archilla-Ortega et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Biomedical application of small extracellular vesicles in cancer treatment
- (2022) Salome Araujo-Abad et al. ADVANCED DRUG DELIVERY REVIEWS
- Next generation of immune checkpoint molecules in maternal‐fetal immunity*
- (2022) Si‐Jia Zhao et al. IMMUNOLOGICAL REVIEWS
- Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study
- (2022) James Welker et al. LANCET INFECTIOUS DISEASES
- Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy
- (2022) Hassan Dianat-Moghadam et al. Stem Cell Research & Therapy
- CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
- (2022) Jimena Álvarez Freile et al. Biomedicines
- Unmet Needs in Oncology Clinical Research and Treatment in Africa: Focus on Ghana
- (2022) Lewis R Roberts et al. ONCOLOGIST
- CD24: A Novel Target for Cancer Immunotherapy
- (2022) Emmanouil Panagiotou et al. Journal of Personalized Medicine
- Polysaccharide immunization and colorectal cancer: A systematic review and network meta-analysis
- (2022) Yuefeng Chen et al. Frontiers in Nutrition
- CD24-gold nanocomposite as promising and sensitive biomarker for cancer stem cells in salivary gland tumors
- (2022) Amina Fouad Farag et al. Nanomedicine-Nanotechnology Biology and Medicine
- Drug resistance in NSCLC is associated with tumor micro-environment
- (2022) Weiguo Zhang et al. Reproductive Biology
- The lipid rafts in cancer stem cell: a target to eradicate cancer
- (2022) Shuo Zhang et al. Stem Cell Research & Therapy
- The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation
- (2022) Xi-Yang Tang et al. Cancers
- Engaging stemness improves cancer immunotherapy
- (2022) Hassan Dianat-Moghadam et al. CANCER LETTERS
- Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors
- (2022) Farhoodeh Ghaedrahmati et al. Cancer Communications
- Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells
- (2021) Dinisha Kamble et al. Cells
- P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression
- (2021) Eilam Yeini et al. Nature Communications
- Resolving the spatial and cellular architecture of lung adenocarcinoma by multiregion single-cell sequencing
- (2021) Ansam Sinjab et al. Cancer Discovery
- A Comparative in Silico Analysis of CD24’s Prognostic Value in Human and Canine Prostate Cancer
- (2021) Antonio Fernando Leis-Filho et al. Journal of Personalized Medicine
- CD24 for Cardiovascular Researchers: A Key Molecule in Cardiac Immunology, Marker of Stem Cells and Target for Drug Development
- (2021) Eyal Sagiv et al. Journal of Personalized Medicine
- Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma
- (2021) KYOSUKE AGAWA et al. ANTICANCER RESEARCH
- Glycosylation Modulates Plasma Membrane Trafficking of CD24 in Breast Cancer Cells
- (2021) Amanda Chantziou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ELF5 inhibits the proliferation and invasion of breast cancer cells by regulating CD24
- (2021) Xinjian Qu et al. MOLECULAR BIOLOGY REPORTS
- Translocation of intracellular CD24 constitutes a triggering event for drug resistance in breast cancer
- (2021) Hugo Werner Huth et al. Scientific Reports
- Potential Role of CD47-Directed Bispecific Antibodies in Cancer Immunotherapy
- (2021) Yan Yang et al. Frontiers in Immunology
- Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies
- (2021) Shiran Shapira et al. Journal of Personalized Medicine
- Trans-ethnic genome-wide association study of severe COVID-19
- (2021) Peng Wu et al. Communications Biology
- The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders
- (2021) Upasana Parthasarathy et al. BIOCHEMICAL PHARMACOLOGY
- Single-cell mass cytometry reveals cross-talk between inflammation-dampening and inflammation-amplifying cells in osteoarthritic cartilage
- (2020) Fiorella Carla Grandi et al. Science Advances
- Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
- (2020) Nastassja Terraneo et al. Frontiers in Oncology
- A Dinucleotide Deletion in the CD24 Gene Is a Potential Risk Factor for Colorectal Cancer
- (2020) Lior Segev et al. AMERICAN SURGEON
- CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy
- (2020) Yang-Hong Ni et al. CURRENT GENE THERAPY
- Novel insights into the function of CD24 : a driving force in cancer
- (2020) Peter Altevogt et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10
- (2020) Shan-Shan Yin et al. Frontiers in Immunology
- Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies
- (2020) Lia Walcher et al. Frontiers in Immunology
- CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model
- (2020) Katrin Kleinmanns et al. EBioMedicine
- CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non‐small cell lung cancer with PD‐L1 TPS
- (2020) Yuichi Ozawa et al. CANCER SCIENCE
- Cancer and the Microbiome—Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy
- (2020) Vyara Matson et al. GASTROENTEROLOGY
- The Emerging Role of CD24 in Cancer Theranostics—A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond
- (2020) Katrin Kleinmanns et al. Journal of Personalized Medicine
- Anti-CD24 antibody-nitric oxide conjugate (ANC) selectively and potently suppresses hepatic carcinoma
- (2019) Fumou Sun et al. CANCER RESEARCH
- Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
- (2019) Shangze Li et al. CANCER RESEARCH
- Heparanase promotes glioma progression via enhancing CD24 expression
- (2019) Uri Barash et al. INTERNATIONAL JOURNAL OF CANCER
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
- (2019) Dong Yang et al. Journal for ImmunoTherapy of Cancer
- Presence and role of stem cells in ovarian cancer
- (2019) Natasa Kenda Suster et al. World Journal of Stem Cells
- The role of CD24 in multiple myeloma tumorigenicity and effects of the microenvironment on its expression
- (2019) Nechama Gilad et al. Oncotarget
- MicroRNA‐3064‐5p sponged by MALAT1 suppresses angiogenesis in human hepatocellular carcinoma by targeting the FOXA1/CD24/Src pathway
- (2019) Pei Zhang et al. FASEB JOURNAL
- GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells
- (2019) Christian M. Seitz et al. OncoImmunology
- Inhibition of Elevated Hippocampal CD24 Reduces Neurogenesis in Mice With Traumatic Brain Injury
- (2019) Han Wang et al. JOURNAL OF SURGICAL RESEARCH
- Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy
- (2018) Shirin Eyvazi et al. CURRENT CANCER DRUG TARGETS
- Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems
- (2018) Hassan Dianat-Moghadam et al. JOURNAL OF CONTROLLED RELEASE
- Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
- (2018) Piyush B. Gupta et al. Cell Stem Cell
- Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as Monotherapy
- (2018) Mark Ayers et al. CLINICAL CANCER RESEARCH
- Pembrolizumab in patients with programmed death ligand 1–positive advanced ovarian cancer: Analysis of KEYNOTE-028
- (2018) Andrea Varga et al. GYNECOLOGIC ONCOLOGY
- Cancer stem cells (CSCs) in cancer progression and therapy
- (2018) Masoud Najafi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Overview of CD24 as a new molecular marker in ovarian cancer
- (2018) Vahideh Tarhriz et al. JOURNAL OF CELLULAR PHYSIOLOGY
- iNOS promotes CD24+CD133+ liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway
- (2018) Ronghua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- The CD24 surface antigen in neural development and disease
- (2017) Daniel T. Gilliam et al. NEUROBIOLOGY OF DISEASE
- CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
- (2017) Kiyoko Nakamura et al. ONCOLOGY REPORTS
- CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer
- (2017) Xinyu Deng et al. Oncotarget
- Hedgehog signaling pathway regulates ovarian cancer invasion and migration via adhesion molecule CD24
- (2017) Chunyan Zeng et al. Journal of Cancer
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cells
- (2016) Kumi Suyama et al. CANCER LETTERS
- Cancer stem cells, cancer-initiating cells and methods for their detection
- (2016) Shiva Akbari-Birgani et al. DRUG DISCOVERY TODAY
- Both bulk and cancer stem cell subpopulations in triple-negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition
- (2016) Andrew Sulaiman et al. FEBS LETTERS
- Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal–maternal interface
- (2016) Marei Sammar et al. HISTOCHEMISTRY AND CELL BIOLOGY
- CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells
- (2016) Ben Davidson HUMAN PATHOLOGY
- Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
- (2016) Rita Nanda et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer stem cell signaling pathways
- (2016) William H. Matsui MEDICINE
- The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+/CD24− phenotype
- (2016) Haishan Zhao et al. Molecular Medicine Reports
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- Wnt Signaling in Cancer Stem Cell Biology
- (2016) Felipe de Sousa e Melo et al. Cancers
- Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers
- (2016) Shiran Shapira et al. PLoS One
- PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells
- (2015) Jiezhong Chen et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
- (2015) D. Burgos-Ojeda et al. MOLECULAR CANCER THERAPEUTICS
- CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
- (2015) Mi Jeong Kwon et al. PLoS One
- CD24 promotes HCC progression via triggering Notch-related EMT and modulation of tumor microenvironment
- (2015) Xin Wan et al. TUMOR BIOLOGY
- Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells
- (2015) Ronghua Wang et al. Oncotarget
- Leishmania infantum Amastigotes Trigger a Subpopulation of Human B Cells with an Immunoregulatory Phenotype
- (2015) Guadalupe Andreani et al. PLoS Neglected Tropical Diseases
- CD24 regulates stemness and the epithelial to mesenchymal transition through modulation of Notch1 mRNA stability by p38MAPK
- (2014) Juyeon Lim et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells
- (2014) Mari Hosonaga et al. CANCER SCIENCE
- The effects of STAT3 and Survivin silencing on the growth of human bladder carcinoma cells
- (2014) Baogang Zhang et al. TUMOR BIOLOGY
- PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activation
- (2013) E Seront et al. BRITISH JOURNAL OF CANCER
- The immunohistochemical expression of CD24 and CD171 adhesion molecules in borderline ovarian tumors
- (2013) Alexandra Moulla et al. POLISH JOURNAL OF PATHOLOGY
- Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies
- (2012) H. Zhou et al. CARCINOGENESIS
- CD24 controls Src/STAT3 activity in human tumors
- (2012) Niko P. Bretz et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
- (2012) Erhong Meng et al. CLINICAL & EXPERIMENTAL METASTASIS
- Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
- (2012) M. Sen et al. CLINICAL CANCER RESEARCH
- Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer
- (2012) Ning Su et al. Molecular Cancer
- Intracellular CD24 Inhibits Cell Invasion by Posttranscriptional Regulation of BART through Interaction with G3BP
- (2011) K. Taniuchi et al. CANCER RESEARCH
- CD24 interacts with and promotes the activity of c-src within lipid rafts in breast cancer cells, thereby increasing integrin-dependent adhesion
- (2011) Petra Baumann et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
- (2011) S. Ricardo et al. JOURNAL OF CLINICAL PATHOLOGY
- Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
- (2011) Siyuan Zhang et al. NATURE MEDICINE
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
- (2010) H. Harrison et al. CANCER RESEARCH
- CD24: from A to Z
- (2010) Xianfeng Fang et al. Cellular & Molecular Immunology
- Targeting Notch to Target Cancer Stem Cells
- (2010) A. Pannuti et al. CLINICAL CANCER RESEARCH
- Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis
- (2010) Glen Kristiansen et al. LABORATORY INVESTIGATION
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- A Novel Splice Variant of GLI1 That Promotes Glioblastoma Cell Migration and Invasion
- (2009) H.-W. Lo et al. CANCER RESEARCH
- CD24-dependent MAPK pathway activation is required for colorectal cancer cell proliferation
- (2009) Weifei Wang et al. CANCER SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started